Roche: Analyst consensus compiled by the company shows that biosimilar drugs are expected to create a sales gap of 6.2 billion Swiss francs by 2030.

Zhitongcaijing · 2d ago
Roche: Analyst consensus compiled by the company shows that biosimilar drugs are expected to create a sales gap of 6.2 billion Swiss francs by 2030.